Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.350
-0.060 (-4.26%)
At close: Feb 11, 2026, 4:00 PM EST
1.310
-0.040 (-2.96%)
After-hours: Feb 11, 2026, 7:59 PM EST
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $3.63 million as of February 11, 2026. Its market cap has decreased by -95.94% in one year.
Market Cap
3.63M
Enterprise Value
10.30M
1-Year Change
-95.94%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $3.63M, a decrease of -98.96%. That is a compound annual growth rate of -69.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.79M | -73.28% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 4.45M |
| Abpro Holdings | 4.13M |
| Matinas BioPharma Holdings | 4.04M |
| Indaptus Therapeutics | 4.01M |
| Dermata Therapeutics | 3.84M |
| Silo Pharma | 3.79M |
| Moolec Science | 3.73M |
| Galmed Pharmaceuticals | 3.73M |